Malignant pleural mesothelioma: overview of the North American and European experience.
MPM is an uncommon disease with limited treatment options. Early diagnosis, a standardized staging system, early referral to centers experienced in MPM, and efforts to develop collaborative multicenter trials are essential to improving treatment for patients with MPM. Efforts to manage this malignancy, which is projected to peak in the twenty-first century, constitute an important international health concern, particularly because the use of asbestos, despite successful regulatory efforts in many parts of the world, continues unabated in others.
Kukreja
Jasleen
J
Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
Jaklitsch
Michael T
MT
Wiener
Daniel C
DC
Sugarbaker
David J
DJ
Burgers
Sjaak
S
Baas
Paul
P
D003131:Combined Modality Therapy; D005060:Europe / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008654:Mesothelioma / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D009367:Neoplasm Staging; D009656:North America / Q000453:epidemiology; D010997:Pleural Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D011379:Prognosis; D015996:Survival Rate